Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#4532 Gender differences in patients with medullary thyroid cancer (MTC): A single-centre experience
Introduction: Medullary thyroid cancer (MTC) accounts for 3-5% of thyroid tumours. It can be sporadic or associated with genetic syndrome. The role of gender in the MTC isn’t clarified.
Conference:
Presenting Author:
Authors: Cannavale G, Minotta R, Liccardi A, Benevento E, Di Iasi G,
Keywords: MTC, gender difference, gender medicine,
Introduction: Multiple Endocrine Neoplasia type 2 (MEN2) is caused by germline pathogenic variants (PVs) in the RET proto-oncogene, leading to medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism (PHPT). RET c.1998G>C, p.Lys666Asn is a rare PV, with 33 cases described thus far, and is associated with low penetrance of MEN2-related tumours, but its clinical significance remains incompletely understood.
Conference:
Presenting Author: Halperin R
Authors: Halperin R, Peshes-Yaloz N, Tirosh A, Twito O,
Keywords: MEN2, pheochromocytoma, hyperparathyroidism, medullary thyroid carcinoma,
Introduction: Serum levels of growth factors associated with endocrine tumours may be potentially useful in detecting their recurrence.
Conference:
Presenting Author: Opalinska M
Authors: Opalinska M, Kurzynska A, Morawiec-Slawek K, Stefanska A, Kolasa M,
Keywords: growth factor, endocrine tumour, TNF-α, Fascin, recurrence risk,
#4317 Late diagnosis of MEN2A syndrome: Ten cases in one family
Introduction: Multiple endocrine neoplasia type 2 (MEN2) constitutes a rare hereditary cancer syndrome affecting various endocrine glands.
Conference:
Presenting Author:
Authors: Asanova A, Shutova A, Dzeranova L, Przhiyalkovskaya E, Pigarova E,
Keywords: MEN2A, RET, MTC, THYROIDECTOMY,
#4216 Immunohistochemical analysis for galectin-3 and outcomes in medullary thyroid cancer
Introduction: Galectin-3 (Gal-3) is a beta-galactoside involved in multiple biological and pathological processes including growth and differentiation, cellular adhesion and transformation, and metastatic potential.
Conference:
Presenting Author: Raia S
Authors: Raia S, Chiloiro S, Giampietro A, Lugli F, Maratta M,
Keywords: Thyroid, MTC, Galectine3,